Anze Yu

1.2k total citations · 1 hit paper
25 papers, 643 citations indexed

About

Anze Yu is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Anze Yu has authored 25 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Anze Yu's work include Cancer Immunotherapy and Biomarkers (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Ferroptosis and cancer prognosis (5 papers). Anze Yu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Ferroptosis and cancer prognosis (5 papers). Anze Yu collaborates with scholars based in China, United States and Germany. Anze Yu's co-authors include Xiongbing Zu, Jiao Hu, Jinbo Chen, Huihuang Li, Belaydi Othmane, Wenbiao Ren, Minfeng Chen, Dongxu Qiu, Guanghui Gong and Peihua Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Death and Differentiation and Cellular and Molecular Life Sciences.

In The Last Decade

Anze Yu

24 papers receiving 642 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

2021 250 citations Jiao Hu, Anze Yu et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anze Yu China	12	308	264	199	191	166	25	643
Francesca Simionato Italy	17	290 0.9×	199 0.8×	455 2.3×	199 1.0×	125 0.8×	31	794
Yuchen Han China	16	312 1.0×	424 1.6×	368 1.8×	184 1.0×	88 0.5×	82	899
Chao‐Nan Qian China	14	208 0.7×	276 1.0×	309 1.6×	146 0.8×	242 1.5×	33	812
Naoyuki Okabe Japan	15	212 0.7×	255 1.0×	392 2.0×	197 1.0×	61 0.4×	56	706
Dongxu Qiu China	10	192 0.6×	218 0.8×	136 0.7×	108 0.6×	120 0.7×	39	547
Fengkai Xu China	17	645 2.1×	199 0.8×	246 1.2×	319 1.7×	82 0.5×	35	983
Nobue Kumaki Japan	14	135 0.4×	144 0.5×	300 1.5×	201 1.1×	109 0.7×	47	600
Yayun Zhu China	13	217 0.7×	233 0.9×	473 2.4×	291 1.5×	130 0.8×	22	744
Marie Lundholm Sweden	14	423 1.4×	272 1.0×	313 1.6×	319 1.7×	74 0.4×	32	1.0k
Yasuhiro Chikaishi Japan	14	145 0.5×	291 1.1×	320 1.6×	80 0.4×	84 0.5×	60	608

Countries citing papers authored by Anze Yu

Since Specialization

Citations

This map shows the geographic impact of Anze Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anze Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anze Yu more than expected).

Fields of papers citing papers by Anze Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anze Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anze Yu. The network helps show where Anze Yu may publish in the future.

Co-authorship network of co-authors of Anze Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Anze Yu. A scholar is included among the top collaborators of Anze Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anze Yu. Anze Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Kangbo, Minyu Chen, Yuhang Chen, et al.. (2025). Deciphering the Immunomodulatory Function of GSN ⁺ Inflammatory Cancer‐Associated Fibroblasts in Renal Cell Carcinoma Immunotherapy: Insights From Pan‐Cancer Single‐Cell Landscape and Spatial Transcriptomics Analysis. Cell Proliferation. 58(12). e70062–e70062. 1 indexed citations

Xu, Xiaowen, Yingjie Shen, Jingjing Jiang, et al.. (2025). Clinical and genetic features of older patients with pheochromocytomas and paragangliomas: A multicenter retrospective study. Journal of Endocrinological Investigation. 49(1). 81–91.

Yu, Anze, Yinghan Wang, Zhiyu Dai, et al.. (2024). Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer. Cellular and Molecular Life Sciences. 81(1). 292–292. 1 indexed citations

Yu, Anze, Liangmin Fu, Rui Yang, et al.. (2024). Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis. Cell Death and Differentiation. 32(4). 776–791. 7 indexed citations

Yu, Anze, Jiao Hu, Liangmin Fu, et al.. (2023). Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8⁺ T cell infiltration and functional transition. Journal for ImmunoTherapy of Cancer. 11(10). e007230–e007230. 14 indexed citations

Zhang, Xiaolong, Xiang Xiao, Jinfei Fu, et al.. (2023). The transcription factor IRF4 determines the anti-tumor immunity of CD8+ T cells. iScience. 26(11). 108087–108087. 8 indexed citations

Yu, Anze, et al.. (2023). PD-L1 Expression is Linked to Tumor-Infiltrating T-Cell Exhaustion and Adverse Pathological Behavior in Pheochromocytoma/Paraganglioma. Laboratory Investigation. 103(9). 100210–100210. 8 indexed citations

Hu, Jiao, Belaydi Othmane, Anze Yu, et al.. (2021). 5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer. BMC Medicine. 19(1). 289–289. 52 indexed citations

Hu, Junwen M., Dongxu Qiu, Anze Yu, et al.. (2021). YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Frontiers in Oncology. 11. 607224–607224. 86 indexed citations

10.

Li, Huihuang, Jiao Hu, Anze Yu, et al.. (2021). RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma. Frontiers in Oncology. 11. 642159–642159. 27 indexed citations

11.

Quan, Chao, Belaydi Othmane, Jiao Hu, et al.. (2021). N6-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target. Frontiers in Immunology. 12. 697026–697026. 20 indexed citations

12.

Yu, Anze, et al.. (2021). Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis. Bioscience Reports. 41(8). 11 indexed citations

13.

Hu, Jiao, Anze Yu, Belaydi Othmane, et al.. (2021). Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer. Theranostics. 11(7). 3089–3108. 250 indexed citations breakdown →

14.

Qiu, Dongxu, Junwen M. Hu, Jiao Hu, et al.. (2021). PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer. Frontiers in Immunology. 12. 705086–705086. 16 indexed citations

15.

Yu, Anze, Minghao Li, Changsheng Xing, et al.. (2020). A Comprehensive Analysis Identified the Key Differentially Expressed Circular Ribonucleic Acids and Methylation-Related Function in Pheochromocytomas and Paragangliomas. Frontiers in Genetics. 11. 15–15. 8 indexed citations

16.

Liu, Peihua, Qi Lin, Xiang Chen, et al.. (2020). Clinical and genetic features of pediatric PCCs/PGLs patients: a single-center experience in China. Translational Andrology and Urology. 9(2). 267–275. 4 indexed citations

17.

Fu, Jinfei, Anze Yu, Juyu Tang, Bin He, & Wenhao Chen. (2020). Adoptive CD8⁺ T cell therapy generates immunological memory to inhibit melanoma metastasis.. PubMed. 12(11). 7262–7274. 1 indexed citations

18.

Zhang, Xinyi, Changsheng Xing, Lang Chen, et al.. (2020). Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis. Cancer Cell International. 20(1). 169–169. 15 indexed citations

19.

Liu, Peihua, Minghao Li, Xiao Guan, et al.. (2018). Clinical Syndromes and Genetic Screening Strategies of Pheochromocytoma and Paraganglioma. SHILAP Revista de lepidopterología. 5(4). 14–22. 14 indexed citations

20.

Yi, Xiaoping, Xiao Guan, Chen Chen, et al.. (2018). Adrenal incidentaloma: machine learning-based quantitative texture analysis of unenhanced CT can effectively differentiate sPHEO from lipid-poor adrenal adenoma. Journal of Cancer. 9(19). 3577–3582. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact